ROCHE Farmaceutica Quimica, Lda. secures contract for Antineoplastic and immunomodulating agents - 2023/0491 - PERTUZUMAB TRASTUZUMAB [60 60 MG/ML; SOL INJ; FRS] (P1659)

Portugal, May 6 -- Portugal based ROCHE Farmaceutica Quimica, Lda. has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - PERTUZUMAB TRASTUZUMAB [60 60 MG/ML; SOL INJ; FRS] (P1659). The value of the contract is worth 38014460 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....